Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financi... (net loss per share $ (0.46)$ (0.33)$ ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results

Date:2/28/2013

net loss per share

$
(0.46)$
(0.33)$
(1.50)$
(1.19)Weighted average shares outstanding used in computing basic and diluted net loss per share115,179114,446114,820112,942 NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands)(Unaudited)Twelve Months Ended December 31,20122011Cash flows from operating activities:Net loss

$
(171,855)$
(133,978)Adjustments to reconcile net loss to net cash used in operating activities:Non-cash interest expense on liability related to sale of future royalties

18,057-Non-cash royalty revenue related to sale of future royalties

(10,791)-Stock-based compensation

16,19918,885Depreciation and amortization

14,50814,951Impairment of long-lived assets

1,675-Other non-cash transactions

8451,359Changes in operating assets and liabilities:Accounts receivable

(867)20,164Inventory

(5,613)(5,390)Other assets

6,031(12,267)Accounts payable

(122)(3,384)Accrued compensation

(4,034)3,555Accrued expenses

1,4951,013Accrued clinical trial expenses

5,547(191)Deferred revenue

(9,384)(17,516)Interest payable

5,278-Other liabilities

3,275(943)Net cash used in operating activities

(129,756)(113,742)Cash flows from investing activities:Purchases of property and equipment

(10,583)(9,722)Restricted cash

(25,000)-Maturities of investments

307,887383,052Sales of investments

5,378210,089Purchases of investments

(164,662)(695,371)Net cash provided by (used in) investing activities

113,020(111,952)Cash flows from financing activities:Proceeds from issuance of senior secured notes, net

77,940-Repayment of convertible subordinated notes

(172,407)-Payment of capital lease obligations

(2,437)(1,978)Proceeds from sale of f
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine technology :

1. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
2. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
3. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
4. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets

Post Your Comments:

(Date:5/17/2013)... CHAPEL HILL, N.C. , May 17, 2013 ... on how organizations communicate internally. Faced with a ... adjust their strategies and tactics for communicating with ... the effectiveness of all the strategies, tactics and ... In a new study, Best ...

(Date:5/17/2013)... 17, 2013 Sony Biotechnology Inc. ("Sony") today announced ... (SP6800). Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22. The ... commercial audio-visual technologies into new and novel functionalities for ...

(Date:5/17/2013)... TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...

Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2 Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2 TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2

[0] Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness [0] Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color [0] TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map

... PARK, Calif., Sept. 14 Praxis EMR has submitted its ... EMRs to apply for HITECH certification in the country. Under ... in federal incentives if they can demonstrate "meaningful use" of ... the U.S. Department of Health and Human Services to test ...

... Reportlinker.com announces that a new market research ... Autistic Disorder - Pipeline Assessment and Market ... Autistic Disorder - Pipeline ... SummaryGlobalData, the industry analysis specialist, has released ...

Cached Medicine Technology:Praxis EMR Among First to Apply for HITECH Certification 2 Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 2 Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 3

Praxis EMR Among First to Apply for HITECH Certification Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017

(Date:5/19/2013)... 2013 These molecular diagnostics market ... Spain, Japan, Italy, Germany and France:, ... laboratory practice, as well as key economic, regulatory, ... impact during the next five years. , ... technologies, test formats, detection methodologies, trends in testing ...

(Date:5/19/2013)... May 19, 2013 Americans live closer ... the newest American Veterinary Medical Association (AVMA) U.S. Pet ... dog owners consider their dog a member of the ... said as much five years earlier. , According to ... of the national income dedicated to pets has increased ...

(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...

(Date:5/19/2013)... Passages Malibu, the leading non-12 step, holistic, and ... the launch of a “Sobriety, Health, and Wellness” survey ... “We are always looking for new ways to engage ... regarding sobriety, what’s working for people, and what isn’t,” ... Passages Addiction Treatment Centers located in Malibu and ...

(Date:5/19/2013)... HealthEconomics.Com , the global leader ... unveil a new and exciting service: HE-Xpo: a media-rich, ... array of real-time communication tools to expand their digital ... , HE-Xpo is powered by OnStream Media’s ... feel of being at a physical trade show, all ...

Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3 Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2 Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3 Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2 Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3

[0] Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com [0] Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing [0] VegasHotelEscapes.com Announces Special Vegas Packages For Billboard Music Awards [0] Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey [0] HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access

... Programs During the Quarter, PALO ALTO, Calif., Nov. ... announced financial results for,the quarter ended September 30, 2007. ... of 2007 was $19.4,million, compared to net income of ... in the quarter ended September 30, 2006 included $31.6,million ...

... NEW YORK, Nov. 6 Weight Watchers,International, Inc. (NYSE: ... 29, 2007. Third Quarter 2007 Results For the ... to $337.5 million, up from $284.8 million in the third ... in the third quarter,of 2007 to $0.62 versus $0.52 in ...

... looks at hospital discharge rates in Raleigh and 6 ... ... County EMS has,participated in a seven-city study on the impact of new ... Heart,Association,s new 2005 CPR guidelines, according to the study authors in a,presentation ...

... rates in Cypress Creek and ... 6 other cities, ... in a seven-city study on the impact of new CPR techniques,the results ... CPR guidelines, according to the study authors in a,presentation at the AHA,s ...

... with Cardiac Resynchronization Therapy, researchers say , TUESDAY, Nov. ... a device that synchronizes pumping in the heart,s ventricles ... The results were presented Tuesday at a late-breaking clinical ... in Orlando, Fla., and were expected to be published ...

... Institute of Allergy and Infectious Diseases (NIAID), part of ... to strengthen and expand its nationwide group of institutions ... for infectious diseases. In addition to increasing the number ... Vaccine and Treatment Evaluation Units (VTEUs) to carry out ...

Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results Weight Watchers Announces Third Quarter 2007 Results Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device Cypress Creek in National Study, Shows Survival To Hospital Discharge After Cardiac Arrest Doubles with Improved CPR and Impedance Threshold Device Cardiac Device Won't Help Some Heart Failure Patients NIAID strengthens and expands Vaccine and Treatment Evaluation Units

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Xylocaine White Blood Cell Count Western Equine Encephalitis Antibody, IgM by IFA, Serum West Nile Virus RNA by RT-PCR